insights_auto
Why is AIM down 4.10%?
Dive Deeperchevron_right
AIM:NYSEAMERICAN
AIM ImmunoTech Inc
$0.18
arrow_downward
-4.10%(-0.0077) 1D
$0.19
arrow_upward
+3.28% (+0.0059)bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AIM...
Open
$0.19
High
$0.19
Low
$0.18
Mkt. cap
7.09M
Avg. vol.
8.71M
Volume
1.33M
52-wk high
$2.88
52-wk low
$0.17
EPS
-$3.93
Beta
1.27
Shares outstanding
39.18M
No. of employees
20
Open
$0.19
High
$0.19
Low
$0.18
Mkt. cap
7.09M
Avg. vol.
8.71M
Volume
1.33M
52-wk high
$2.88
52-wk low
$0.17
EPS
-$3.93
Beta
1.27
Shares outstanding
39.18M
No. of employees
20
News stories
From web sources and news partners
BigGo Finance
·
30 minutes ago
Hang Seng Tech Tumbles Nearly 40% in a Year While Nasdaq Keeps Hitting Records — Why the Same AI Cycle Produced Divergent Paths
PR Newswire
·
5 minutes ago
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
ETF Database
·
12 hours ago
S&P 500 Snapshot: Stocks Rally to Close Out Flat Week
RealClearMarkets
·
2 hours ago
Here Are the Corporations Joining S&P 500
Profile
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
About AIM ImmunoTech Inc
CEO-
Employees20
Founded1966
HeadquartersPhiladelphia, Pennsylvania, United States
SectorBiotechnology
Websiteaimimmuno.com